FDA Inspection
Bora Pharmaceuticals (frmly: TWI Pharmaceuticals, Inc.)Bora Pharmaceuticals (frmly: TWI Pharmaceuticals, Inc.) – FDA Inspection, Mar 27, 2026
Record Details
This FDA Inspection record concerns Bora Pharmaceuticals (frmly: TWI Pharmaceuticals, Inc.), with an inspection on March 27, 2026, issued by the Office of Inspections and Investigations, covering human drugs.
- Inspection Date
- March 27, 2026
- Product Type
- Human Drugs
View Company Profile
ID · ba483e74-0c81-448a-8ec3-05059034c57b
Inspection Facts
- Inspection number
- 1305502
- FDA center
- Human Drugs
Other FDA inspections of Bora Pharmaceuticals (frmly: TWI Pharmaceuticals, Inc.)
6| Date | Classification | Office | Project area |
|---|---|---|---|
| February 7, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 23, 2019 | Not classified | Office of Inspections and Investigations | |
| July 13, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 16, 2016 | Not classified | Office of Inspections and Investigations | |
| May 15, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Bora Pharmaceuticals (frmly: TWI Pharmaceuticals, Inc.)
- FDA Inspection 1119432 - 2020-02-07
- FDA Inspection 1103589 - 2019-08-23
- FDA Inspection 1061565 - 2018-07-13
- FDA Inspection 998389 - 2016-12-16
- FDA Inspection 881386 - 2014-05-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.